Stock warrant tracker
Every outstanding warrant series recorded in a Signal8 dilution snapshot, one row per series: the shares it can be exercised into, the exercise price (strike), the expiry date, whether the price can reset after a later financing, and the SEC filing each figure was read from. Exercise prices and share counts are restated for every stock split since the filing, so they compare directly with the current share price.
5,302 warrant series at 1,050 companies. 778 in the money, 59 expiring in the next 30 days, 37 waiting on a stockholder vote or other stated condition, 4 becoming exercisable in the next 30 days.
Outstanding warrants
| Series | Shares | Exercise price | Last price | Vs strike | Expiry | Exercisable | Terms | Overhang | Source | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Public Warrants (Colombier IPO, NYSE: PSQH.WS) | $0.5200 | $2.3M | 424B5, Dec 19, 2025Dilution tabAs of Nov 8, 2026 | ||||||||
| June 2026 Milestone Series A Warrants | $0.9494 | $2.3M | DEF 14A, Aug 4, 2026Dilution tabAs of Nov 14, 2026 | ||||||||
| June 2026 Milestone Series C Warrants | $0.9494 | $2.3M | DEF 14A, Aug 4, 2026Dilution tabAs of Nov 14, 2026 | ||||||||
| June 2026 Placement Agent Warrants (Curvature Securities and designees) | $0.9494 | $2.3M | DEF 14A, Aug 4, 2026Dilution tabAs of Nov 14, 2026 | ||||||||
| Legacy Decoy warrants assumed in asset acquisition (Merger) | $0.9494 | $2.3M | 10-K, Mar 31, 2026Dilution tabAs of Nov 14, 2026 | ||||||||
| Legacy warrants issued 2020-2023 | $0.9494 | $2.3M | 10-K, Mar 31, 2026Dilution tabAs of Nov 14, 2026 | ||||||||
| November 2025 Offering Series A Warrants | $0.9494 | $2.3M | 10-Q, Nov 12, 2026Dilution tabAs of Nov 14, 2026 | ||||||||
| November 2025 Offering Series B Warrants | $0.9494 | $2.3M | 10-Q, Nov 12, 2026Dilution tabAs of Nov 14, 2026 | ||||||||
| Representative Warrants (November 2025, Ladenburg Thalmann) | $0.9494 | $2.3M | S-1, Oct 7, 2026Dilution tabAs of Nov 14, 2026 | ||||||||
| September 2026 New Warrants (Inducement) | $0.9494 | $2.3M | 10-Q EX-4.1, Nov 12, 2026Dilution tabAs of Nov 14, 2026 | ||||||||
| Representative's Warrant (Network 1 Financial Securities, Inc.) — July 2023 IPO underwriter compensation | $0.7662 | $2.2M | S-1/A EX-4.2, Jul 17, 2023Dilution tabAs of Oct 21, 2026 | ||||||||
| Amended March 2023 / July 2023 Warrants (repriced March 2024) | $1.67 | $2.2M | 10-K, Mar 30, 2026Dilution tabAs of Nov 14, 2026 | ||||||||
| March 2024 Common Warrants | $1.67 | $2.2M | 10-K, Mar 30, 2026Dilution tabAs of Nov 14, 2026 | ||||||||
| March 2024 Placement Agent Warrants | $1.67 | $2.2M | 10-K, Mar 30, 2026Dilution tabAs of Nov 14, 2026 | ||||||||
| October 2025 Placement Agent Warrants I | $1.67 | $2.2M | 10-Q, Nov 13, 2026Dilution tabAs of Nov 14, 2026 | ||||||||
| October 2025 Placement Agent Warrants II | $1.67 | $2.2M | 10-Q, Nov 13, 2026Dilution tabAs of Nov 14, 2026 | ||||||||
| October 2025 Private Warrants I | $1.67 | $2.2M | 10-Q, Nov 13, 2026Dilution tabAs of Nov 14, 2026 | ||||||||
| October 2025 Private Warrants II | $1.67 | $2.2M | 10-Q, Nov 13, 2026Dilution tabAs of Nov 14, 2026 | ||||||||
| Residual legacy warrants (consultant and other pre-2024 warrants, including one performance-based warrant) | $1.67 | $2.2M | 10-Q, Nov 13, 2026Dilution tabAs of Nov 14, 2026 | ||||||||
| August 2024 Common Warrants (concurrent private placement) | $4.10 | $2.2M | 10-K, Mar 11, 2026Dilution tabAs of Nov 13, 2026 | ||||||||
| August 2024 Placement Agent Warrants | $4.10 | $2.2M | 10-K, Mar 11, 2026Dilution tabAs of Nov 13, 2026 | ||||||||
| August 2026 Common Warrants (concurrent private placement) | $4.10 | $2.2M | 10-Q, Nov 12, 2026Dilution tabAs of Nov 13, 2026 | ||||||||
| August 2026 Placement Agent (PA) Warrants | $4.10 | $2.2M | 424B3, Aug 26, 2026Dilution tabAs of Nov 13, 2026 | ||||||||
| January 2026 Inducement Warrants | $4.10 | $2.2M | 424B3, Feb 9, 2026Dilution tabAs of Nov 13, 2026 | ||||||||
| January 2026 Placement Agent Warrants | $4.10 | $2.2M | 424B3, Feb 9, 2026Dilution tabAs of Nov 13, 2026 | ||||||||
| January 2026 Pre-Funded Warrants | $4.10 | $2.2M | 424B3, Feb 9, 2026Dilution tabAs of Nov 13, 2026 | ||||||||
| January 2026 Private Placement Warrants | $4.10 | $2.2M | 424B3, Feb 9, 2026Dilution tabAs of Nov 13, 2026 | ||||||||
| July 2024 Common Warrants (concurrent private placement) | $4.10 | $2.2M | 10-K, Mar 11, 2026Dilution tabAs of Nov 13, 2026 | ||||||||
| June 2025 Placement (Representative) Warrants | $4.10 | $2.2M | 10-K, Mar 11, 2026Dilution tabAs of Nov 13, 2026 | ||||||||
| June 2025 Series A Warrants | $4.10 | $2.2M | 10-K, Mar 11, 2026Dilution tabAs of Nov 13, 2026 | ||||||||
| June 2025 Series B Warrants | $4.10 | $2.2M | 10-K, Mar 11, 2026Dilution tabAs of Nov 13, 2026 | ||||||||
| June 2026 Placement Agent Warrants | $4.10 | $2.2M | DEF 14A, Jul 7, 2026Dilution tabAs of Nov 13, 2026 | ||||||||
| June 2026 Series C Warrants | $4.10 | $2.2M | 10-Q, Nov 12, 2026Dilution tabAs of Nov 13, 2026 | ||||||||
| June 2026 Series D Warrants | $4.10 | $2.2M | 10-Q, Nov 12, 2026Dilution tabAs of Nov 13, 2026 | ||||||||
| November 2024 Placement Agent Warrants | $4.10 | $2.2M | 424B3, Dec 20, 2024Dilution tabAs of Nov 13, 2026 | ||||||||
| November 2024 Series I Common Stock Purchase Warrants | $4.10 | $2.2M | 424B3, Dec 20, 2024Dilution tabAs of Nov 13, 2026 | ||||||||
| November 2024 Series II Common Stock Purchase Warrants | $4.10 | $2.2M | 424B3, Dec 20, 2024Dilution tabAs of Nov 13, 2026 | ||||||||
| Representative's warrants (ThinkEquity LLC) — December 2024 public offering | $0.2738 | $2.2M | 20-F, Apr 29, 2025Dilution tabAs of Oct 5, 2026 | ||||||||
| Bridge Financing Warrants (2023 convertible notes) | $1.08 | $2.2M | 10-Q, Nov 10, 2026Dilution tabAs of Nov 10, 2026 | ||||||||
| Common warrants (other, not itemised) | $1.08 | $2.2M | 10-Q, Nov 10, 2026Dilution tabAs of Nov 10, 2026 | ||||||||
| Placement Agent/Representative Warrants (July 2025 inducement) | $1.08 | $2.2M | 424B5, Sep 11, 2026Dilution tabAs of Nov 10, 2026 | ||||||||
| Representative's Warrants (November 2024 offering) | $1.08 | $2.2M | 424B5, Sep 11, 2026Dilution tabAs of Nov 10, 2026 | ||||||||
| Series A Warrants (November 2024 offering) | $1.08 | $2.2M | 424B5, Sep 11, 2026Dilution tabAs of Nov 10, 2026 | ||||||||
| Series B Warrants (July 2025 inducement) | $1.08 | $2.2M | 424B5, Sep 11, 2026Dilution tabAs of Nov 10, 2026 | ||||||||
| Series E-1 Warrants (August 2026 inducement) | $1.08 | $2.2M | 424B3, Sep 16, 2026Dilution tabAs of Nov 10, 2026 | ||||||||
| Series E-2 Warrants (August 2026 inducement) | $1.08 | $2.2M | 424B3, Sep 16, 2026Dilution tabAs of Nov 10, 2026 | ||||||||
| IPO Underwriter's Warrants (3% of ordinary shares sold in the May 2025 IPO) | $2.33 | $2.2M | F-1/A EX-FILING FEES, Apr 11, 2025Dilution tabAs of Nov 10, 2026 | ||||||||
| Abaca Warrants | $0.0148 | $2.2M | 10-Q, Nov 9, 2026Dilution tabAs of Nov 14, 2026 | ||||||||
| PIPE Warrants | $0.0148 | $2.2M | 10-Q, Nov 9, 2026Dilution tabAs of Nov 14, 2026 | ||||||||
| Private Placement Warrants | $0.0148 | $2.2M | 10-Q, Nov 9, 2026Dilution tabAs of Nov 14, 2026 |
PSQHPSQ Holdings, Inc.$0.5200Last price
Public Warrants (Colombier IPO, NYSE: PSQH.WS)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$2.3M
DCOYDecoy Therapeutics Inc.$0.9494Last price
June 2026 Milestone Series A Warrants
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$2.3M
DCOYDecoy Therapeutics Inc.$0.9494Last price
June 2026 Milestone Series C Warrants
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$2.3M
DCOYDecoy Therapeutics Inc.$0.9494Last price
June 2026 Placement Agent Warrants (Curvature Securities and designees)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$2.3M
DCOYDecoy Therapeutics Inc.$0.9494Last price
Legacy Decoy warrants assumed in asset acquisition (Merger)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$2.3M
DCOYDecoy Therapeutics Inc.$0.9494Last price
Legacy warrants issued 2020-2023
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$2.3M
DCOYDecoy Therapeutics Inc.$0.9494Last price
November 2025 Offering Series A Warrants
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$2.3M
DCOYDecoy Therapeutics Inc.$0.9494Last price
November 2025 Offering Series B Warrants
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$2.3M
DCOYDecoy Therapeutics Inc.$0.9494Last price
Representative Warrants (November 2025, Ladenburg Thalmann)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$2.3M
DCOYDecoy Therapeutics Inc.$0.9494Last price
September 2026 New Warrants (Inducement)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$2.3M
BGLCBioNexus Gene Lab Corp Common stock$0.7662Last price
Representative's Warrant (Network 1 Financial Securities, Inc.) — July 2023 IPO underwriter compensation
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$2.2M
GNPXGenprex, Inc.$1.67Last price
Amended March 2023 / July 2023 Warrants (repriced March 2024)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$2.2M
GNPXGenprex, Inc.$1.67Last price
March 2024 Common Warrants
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$2.2M
GNPXGenprex, Inc.$1.67Last price
March 2024 Placement Agent Warrants
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$2.2M
GNPXGenprex, Inc.$1.67Last price
October 2025 Placement Agent Warrants I
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$2.2M
GNPXGenprex, Inc.$1.67Last price
October 2025 Placement Agent Warrants II
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$2.2M
GNPXGenprex, Inc.$1.67Last price
October 2025 Private Warrants I
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$2.2M
GNPXGenprex, Inc.$1.67Last price
October 2025 Private Warrants II
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$2.2M
GNPXGenprex, Inc.$1.67Last price
Residual legacy warrants (consultant and other pre-2024 warrants, including one performance-based warrant)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$2.2M
NUWENuwellis, Inc.$4.10Last price
August 2024 Common Warrants (concurrent private placement)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$2.2M
NUWENuwellis, Inc.$4.10Last price
August 2024 Placement Agent Warrants
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$2.2M
NUWENuwellis, Inc.$4.10Last price
August 2026 Common Warrants (concurrent private placement)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$2.2M
NUWENuwellis, Inc.$4.10Last price
August 2026 Placement Agent (PA) Warrants
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$2.2M
NUWENuwellis, Inc.$4.10Last price
January 2026 Inducement Warrants
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$2.2M
NUWENuwellis, Inc.$4.10Last price
January 2026 Placement Agent Warrants
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$2.2M
NUWENuwellis, Inc.$4.10Last price
January 2026 Pre-Funded Warrants
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$2.2M
NUWENuwellis, Inc.$4.10Last price
January 2026 Private Placement Warrants
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$2.2M
NUWENuwellis, Inc.$4.10Last price
July 2024 Common Warrants (concurrent private placement)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$2.2M
NUWENuwellis, Inc.$4.10Last price
June 2025 Placement (Representative) Warrants
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$2.2M
NUWENuwellis, Inc.$4.10Last price
June 2025 Series A Warrants
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$2.2M
NUWENuwellis, Inc.$4.10Last price
June 2025 Series B Warrants
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$2.2M
NUWENuwellis, Inc.$4.10Last price
June 2026 Placement Agent Warrants
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$2.2M
NUWENuwellis, Inc.$4.10Last price
June 2026 Series C Warrants
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$2.2M
NUWENuwellis, Inc.$4.10Last price
June 2026 Series D Warrants
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$2.2M
NUWENuwellis, Inc.$4.10Last price
November 2024 Placement Agent Warrants
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$2.2M
NUWENuwellis, Inc.$4.10Last price
November 2024 Series I Common Stock Purchase Warrants
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$2.2M
NUWENuwellis, Inc.$4.10Last price
November 2024 Series II Common Stock Purchase Warrants
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$2.2M
MRMMEDIROM Healthcare Technologies Inc. American Depositary Share$0.2738Last price
Representative's warrants (ThinkEquity LLC) — December 2024 public offering
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$2.2M
AMIXAutonomix Medical, Inc.$1.08Last price
Bridge Financing Warrants (2023 convertible notes)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$2.2M
AMIXAutonomix Medical, Inc.$1.08Last price
Common warrants (other, not itemised)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$2.2M
AMIXAutonomix Medical, Inc.$1.08Last price
Placement Agent/Representative Warrants (July 2025 inducement)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$2.2M
AMIXAutonomix Medical, Inc.$1.08Last price
Representative's Warrants (November 2024 offering)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$2.2M
AMIXAutonomix Medical, Inc.$1.08Last price
Series A Warrants (November 2024 offering)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$2.2M
AMIXAutonomix Medical, Inc.$1.08Last price
Series B Warrants (July 2025 inducement)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$2.2M
AMIXAutonomix Medical, Inc.$1.08Last price
Series E-1 Warrants (August 2026 inducement)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$2.2M
AMIXAutonomix Medical, Inc.$1.08Last price
Series E-2 Warrants (August 2026 inducement)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$2.2M
OFALOFA Group$2.33Last price
IPO Underwriter's Warrants (3% of ordinary shares sold in the May 2025 IPO)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$2.2M
SHFSSHF Holdings, Inc.$0.0148Last price
Abaca Warrants
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$2.2M
SHFSSHF Holdings, Inc.$0.0148Last price
PIPE Warrants
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$2.2M
SHFSSHF Holdings, Inc.$0.0148Last price
Private Placement Warrants
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$2.2M
Source: SEC filings cited in each company’s dilution snapshot, compiled by Signal8, as of November 17, 2026.
Read from 2,062 dilution snapshots. 4,848 of 5,302 series state an exercise price and 3,366 an expiry date. 121 record when exercise begins; that count grows as companies are re-extracted. 631 series are left off because their figures could not be restated for a stock split. 20 companies and 0 series are held back pending review. Share counts, exercise prices, expiry dates and terms are included in Signal8 Pro. Not investment advice.
About this list
Most of the companies listed are small caps and penny stocks, where warrants are routinely issued with registered direct offerings, PIPEs and underwritten unit deals. When a warrant is exercised the company issues new shares, so the list is a record of shares that do not exist yet but can be issued.
Coverage is limited to the companies Signal8 has a dilution snapshot for. A company that is not listed may still have warrants outstanding, and a figure shown as Not stated was not found in the filings read, which is not a statement that it is zero.
The date a warrant first becomes exercisable is recorded only for companies extracted since Signal8 started reading it. Not recorded yet means the snapshot predates that field, not that the warrant is exercisable. Coverage grows as companies are re-extracted.
Frequently asked questions
- What is a stock warrant?
- A warrant gives its holder the right to buy new shares from the company at a fixed exercise price until an expiry date. When warrants are exercised the company issues new shares, which adds to the share count. Unlike an exchange-listed option, a warrant is issued by the company itself, usually alongside a financing.
- What does in the money mean for a warrant?
- A warrant is in the money when the current share price is above its exercise price, so exercising it costs less than buying the shares on the market. This page compares the last price with the exercise price after restating both for any stock split, and says No recent price when there is no price from the last 7 days.
- Which warrants are expiring soon?
- Each row shows the expiry date stated in the filing, and series that expire within 30 days are marked. A warrant that is not exercised by its expiry date lapses and no shares are issued for it. A row whose stated date has passed says so; the filing record does not show whether that series was exercised before it lapsed.
- What is a warrant exercise price reset or full ratchet?
- Some warrants lower their exercise price if the company later sells shares more cheaply. A full ratchet resets it to the new lower price; a weighted-average adjustment moves it part of the way; some warrants reset on a set date to a price tied to the market. A lower exercise price can also raise the number of shares the warrant covers. The Terms column shows the adjustment the filing describes.
- What is a pre-funded warrant?
- A pre-funded warrant is one where the buyer has already paid almost the whole price up front, leaving a nominal exercise price such as $0.0001 per share. It is in the money by construction, so this page marks it as such and does not rank it by distance from the strike.
- Why are exercise prices split-adjusted?
- Filings state exercise prices and share counts as of their filing date. After a reverse split a warrant covers fewer shares at a higher price. Signal8 restates both onto the current share basis; a series whose basis cannot be resolved is left off the page and counted under the table, rather than shown as filed.
- What is warrant overhang?
- Overhang is the number of shares the warrants can be exercised into, shown here as a percentage of shares outstanding, with both figures on the same split basis. Not measured means one of the two figures is missing.
- Where does the data come from and how often is it updated?
- Each row is read from the SEC filings cited in that company’s Signal8 dilution snapshot, and the source filing link on every row opens the document the figures were taken from. The list is rebuilt from the latest snapshots at least every 30 minutes, and each row shows the date of the snapshot it was read from.
Related
- PIPE tracker: private placements and registered directs
- Pending S-1 filings: offerings not yet effective
- Reverse split calendar
- Recently delisted stocks
- High dilution scanner
- Stock dilution checker
- Warrant overhang: how to count shares not issued yet
- Warrant price resets and ratchets explained
- Warrant inducements explained
- Warrants vs options
- How to read the Signal8 dilution tab
Not investment advice.